SAPPORO CLINICAL LABORATORY INC

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2025, SAPPORO CLINICAL LABORATORY INC has already paid €0.14 in dividends. The last payout was in June 2025.

Financials

In the last quarter, SAPPORO CLINICAL LABORATORY INC had revenue of €28.77M and net profit of €212.61K

(EUR)	December 2025	YoY
Revenue	28.77M	-
Gross profit	8.63M	-
Net profit	212.61K	-
EBITDA	1.92M	-

Fundamentals

Metric	Value
Market capitalization	€34.24M
Number of shares	3.12M
52-week high/low	€1,976,447.54 - €10.92
Dividends	No
Beta	0.35
P/E ratio	21.01
PEG ratio	-2.08
P/B ratio	0.53
P/S ratio	0.39

Company profile

Sapporo Clinical Laboratory Inc. operates dispensing pharmacies in Japan. The company offers clinical examination, pathological examination, and holter examination services. It provides food hygiene environmental inspection, including food/processed product, facility hygiene, and food handler inspection services; and radiation management services. In addition, the company develops, sells, and maintains software, such as SCAN clinical testing systems; and offers support services for opening new clinics. Further, it provides HiWeb21 inspection result inquiry services, as well as sells and maintains software relating to clinical testing. The company was incorporated in 1965 and is based in Sapporo, Japan.